Tag: Chemotherapy
Apixaban Prevents VTE in Cancer Patients Initiating Chemotherapy
Major bleeding occurred in more apixaban-treated than control patients
SABCS: T-DM1 Cuts Recurrent Invasive HER2+ Breast CA Risk
Risk reduced with trastuzumab emtansine in those with residual invasive dz at sx after neoadjuvant chemo
ASH: A+CHP Bests CHOP for Peripheral T-Cell Lymphoma
Median progression-free survival improved with A+CHP vs CHOP; similar incidence of adverse events
SABCS: Delaying Chemo Lowers Survival in Triple-Neg Breast CA
Findings show delaying chemo over 30 days postsurgery lowers triple-negative breast cancer survival
FDA Approves New Treatment for Acute Myeloid Leukemia
Randomized clinical trial showed significant improvement in overall survival with Daurismo
Improved Long-Term Pregnancy Outcomes for Goserelin + Chemo
Findings seen in premenopausal women with stage I to IIIA hormone receptor-negative breast cancer
Addition of Elotuzumab Ups PFS in Refractory Multiple Myeloma
In phase 2 trial, longer progression-free survival for elotuzumab with pomalidomide and dexamethasone
Chemoimmunotherapy Ups Survival in Triple-Negative Breast Cancer
Atezolizumab plus nab-paclitaxel prolongs progression-free survival in metastatic disease
CHF in Pregnancy Up for Cancer Survivors With Cardiac Toxicity
Incidence of congestive heart failure at 31 percent among women with a history of cardiotoxicity
Cardiac Monitoring Needed for High-Risk Breast Cancer Patients
Trastuzumab, certain chemo treatments increase patient risk of heart failure
